Groundbreaking immunotherapy trial promises cancer patients with tumours to live 40% longer
\n—————————————
\nA groundbreaking clinical trial has shown that Car T-cell immunotherapy enables cancer patients with advanced solid tumours to live 40% longer than those receiving standard care, The Guardian reported. The world-first randomised controlled trial, conducted in China with over 100 patients suffering from advanced gastric or gastro-oesophageal junction (GEJ) cancer, revealed that patients treated with Car T-cells lived an average of 7.9 months compared to 5.5 months with conventional treatments.<\/p>\n
Car T-cell therapy involves genetically modifying a patient\u2019s own T-cells to better detect and destroy cancer cells. While already successful in blood cancers, this trial marks a milestone for treating solid tumours, which account for about 90% of all cancers.<\/p>\n
The therapy also extended progression-free survival to 3.3 months versus 1.8 months for standard care. Experts at the American Society of Clinical Oncology hailed these results as transformative, with further trials underway exploring Car T-cell therapy for brain tumours such as glioblastoma. This innovation could revolutionize treatment options for patients with limited alternatives.<\/p>\n","protected":false},"excerpt":{"rendered":"
Groundbreaking immunotherapy trial promises cancer patients with tumours to live 40% longer ————————————— A groundbreaking clinical trial has shown that Car T-cell immunotherapy enables cancer patients with advanced solid tumours to live 40% longer than those receiving standard care, The Guardian reported. The world-first randomised controlled trial, conducted in China with over 100 patients suffering …<\/p>\n","protected":false},"author":1,"featured_media":127264,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_108372464460192_245495985553329":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[8955],"tags":[],"class_list":["post-127265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-news"],"yoast_head":"\n